- Report
- February 2022
- 209 Pages
Global
From €4632EUR$4,799USD£3,973GBP
- Report
- August 2022
- 121 Pages
Global
From €1254EUR$1,299USD£1,076GBP
- Report
- March 2022
- 405 Pages
Global
From €4632EUR$4,799USD£3,973GBP
- Report
- April 2019
- 300 Pages
Global
From €4342EUR$4,499USD£3,725GBP
- Report
- December 2021
- 347 Pages
Global
From €5791EUR$6,000USD£4,968GBP
- Report
- July 2020
- 40 Pages
Global
From €3619EUR$3,750USD£3,105GBP
- Report
- February 2020
- 189 Pages
Global
From €7963EUR$8,250USD£6,831GBP
- Report
- June 2020
- 404 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- March 2023
- 308 Pages
Global
From €5309EUR$5,500USD£4,554GBP
- Report
- January 2023
Global
€4826EUR$5,000USD£4,140GBP
- Report
- April 2024
- 101 Pages
From €5309EUR$5,500USD£4,554GBP
- Report
- February 2022
- 312 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Report
- November 2021
- 255 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- July 2021
- 296 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- March 2021
- 99 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- March 2021
- 345 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- September 2019
- 399 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- December 2018
- 235 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- May 2020
- 261 Pages
United Kingdom
€3240EUR$3,474USD£2,685GBP
- Report
- January 2023
- 150 Pages
Global
From €5743EUR$5,950USD£4,926GBP
The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more